| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Yvonne Linney is Director at BNGO. Yvonne Linney's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Yvonne Linney has 10 Form 4 filings on record from May 2020 to May 2026, all as Director at Bionano Genomics (BNGO), 2020–2026.
The 11 reported transactions were 9 option or other derivative awards, 1 option exercise and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $72K.
The only open-market sale was 20,000 shares of BNGO at an average $3.62 on August 15, 2022, about $72K. Twelve months later BNGO was down 91%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | BNGO Bionano Genomics, Inc. | Director | Sale+OE | 20,000 | $3.62 | $72,402.00 | - | -22.5% | -90.7% |